North America Eubiotics Market Size & Outlook, 2022-2030
North America eubiotics market, 2018-2030 (US$M)
Related Markets
North America eubiotics market highlights
- The North America eubiotics market generated a revenue of USD 1,479.8 million in 2022.
- The market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
- In terms of segment, probiotics was the largest revenue generating product in 2022.
- Organic Acids is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 1,479.8 million |
| Market revenue in 2030 | USD 2,654.2 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Probiotics |
| Fastest growing segment | Organic Acids |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Probiotics, Prebiotics, Organic Acids, Phtyogenics |
| Key market players worldwide | DSM Firmenich AG, Mitsui & Co Ltd, Lallemand, Beneo, Kemin Industries, DuPont de Nemours Inc, Novonesis AS ADR, Associated British Foods PLC, Novozymes, Evonik Industries AG, Basf SE, Cargill, Archer-Daniels Midland Co, China National Bluestar Group |
Other key industry trends
- In terms of revenue, North America region accounted for 30.1% of the global eubiotics market in 2022.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 2,654.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Eubiotics Market Scope
Eubiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America eubiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eubiotics market will help companies and investors design strategic landscapes.
Probiotics was the largest segment with a revenue share of 40.51% in 2022. Horizon Databook has segmented the North America eubiotics market based on probiotics, prebiotics, organic acids, phtyogenics covering the revenue growth of each sub-segment from 2018 to 2030.
North America eubiotics market growth can be attributed to the rising demand for animal products and rapidly flourishing animal feed industry. The rising consumption of meat and meat products in the U.S., Canada, and Mexico has led to increased awareness regarding animal health, which, in turn, has bolstered the consumption of animal feed products.
However, the stringent regulations related to animal feed production in North America are expected to hinder the market growth. The U.S. has the presence of some leading feed manufacturers such as Cargill, Incorporated, Provimi North America, Inc., Alltech, ADM, and Land O'Lakes, Inc.
Reasons to subscribe to North America eubiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America eubiotics market databook
-
Our clientele includes a mix of eubiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America eubiotics market , including forecasts for subscribers. This continent databook contains high-level insights into North America eubiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America eubiotics market size, by country, 2018-2030 (US$M)
North America Eubiotics Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
